Analyzing First Light Asset Management's Q3 vs. Q4 2022 Fund Holdings
Ava Hoppe | 8 May, 2023
Investors and market watchers always want to know where the smart money is going. One resource for this type of information is the 13F filing, which institutional investors with more than $100 million in assets under management must file with the Securities and Exchange Commission (SEC) each quarter. The filing discloses the institution's holdings of publicly traded securities, giving insight into the investment manager's strategy and current positioning. One firm whose 13F filings investors might be watching is First Light Asset Management, LLC. Today we will analyze their Q3 vs. Q4 2022 holdings.
In the Q3 13F filing for First Light Asset Management, LLC, the firm reported a total value of $1,486,579,000 in assets under management, with 29 total holdings. By Q4 2022, the firm's total value of assets under management had increased to $1,813,901,000, with 30 total holdings. Let's take a closer look at some significant individual holdings that intrigued us.
#1 Retra pharmaceuticals, INC
First Light Asset Management increased its holding in Retra Pharmaceuticals from 1,054,985 shares in Q3 to 2,062,453 shares in Q4 — a 95% increase. The value of the position grew from $26,512,000 in Q3 to $78,352,000 in Q4, a 195% increase. This kind of massive increase in value is not unusual for pharma and biotech stocks, which have historically been volatile.
#2 Performant Financial Corporation
First Light Asset Management saw its holding in Performant Financial Corporation increase almost 50% from 5,020,107 shares in Q3 to 7,387,280 shares in Q4. The value of the position grew from $9,287,000 in Q3 to $26,668,000 in Q4, an increase of 187%. Performant Financial Corporation is a unique holding in the firm's portfolio since it operates in the financial and business services industry. We will keep an eye to understand the conviction behind this choice.
#3 Urban Edge Properties
Urban Edge Properties is a real estate investment trust (REIT) stock, and First Light Asset Management saw its total shares decrease from 5,939,499 in Q3, dropping to 0 shares in Q4. This is a notable change since REITs usually are seen as long-term investments. We'll watch keenly how First Light chooses to deploy this capital.
#4 Bellus Health INC
First Light Asset Management made a slight adjustment in its holdings in Biotech/Biomedical firm Bellus Health INC. Their total shares dropped from 2,381,857 in Q3 to 2,356,950 in Q4 - a 1% decrease. The value of the position dropped from $25,152,000 in Q3 to $19,374,000 in Q4 - a 23% decrease.
#5 United Therapeutics Corp DEL
First Light Asset Management significantly reduced its position in United Therapeutics Corp Del, which saw the total shares they held decrease from 2,466 to 1,345 - a 45% decrease. The value of this position shrank from $516,000 in Q3 to $374,000 in Q4 - a 27% decrease.
Overall, First Light Asset Management's Q3 vs. Q4 13F filing shows just how active they were this quarter with several notable moves in their portfolio. It will be insightful to see which direction and moves they decide to make next.
Other Posts
- Wealthstar Advisors, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Augustine Asset Management Inc Q1 2023 vs. Q2 2023 13F Holdings Comparison
- The Thrilling Transformations of Fine Capital Partners' Q3 vs Q4 2022 13F Holdings
- Stearns Financial Services Group Q2 2020 vs. Q3 2020 13F Holdings Comparison
- NextGen Fund Hits €1.2 Billion Target, Investing in Green and Connected Infrastructure for the Future
- The Evolution of NS Partners Ltd's Top Holdings: A Q3 2022 vs Q4 2022 Analysis
- Navigating the Future of Healthcare: JLL's Strategic Moves Bolster Industry Leadership
- Exploring Shifting Sands: Navigating the Evolving Landscape of Fund Holdings in Early 2024
- TricorBraun Acquires CanSource: Expanding Opportunities in the Beverage Industry
- Navigating The Winds of Change: A Deep Dive Into Market Trends and Investment Shifts